<DOC>
	<DOCNO>NCT00796419</DOCNO>
	<brief_summary>Acute lung injury ( ALI ) acute respiratory distress syndrome ( ARDS ) similar condition lung critically injure another inflammatory process body . Together affect 150,000 people per year United States , mortality approach 50 % financial burden estimate exceed $ 5 billion . Fluid overload , weight gain , reduce oncotic pressure ( low blood protein ) associate prolonged need mechanical ventilation mortality patient ALI/ARDS . Historical study provide conflict evidence benefit colloid diuretic therapy ALI/ARDS , recent clinical trial demonstrate significant improvement blood oxygen level . The mechanisms benefit yet certain , appear relate albumin 's ( protein medicine ) specific ability influence injury inflammation lung , thus improve ability lung repair exchange oxygen . The purpose project determine effect therapy affect blood protein ability change way lung cardiovascular system ( heart blood vessel ) function . Special measurement take understand protein medicine change ability lung whole body recover widespread injury , additional measure specific heart lung function . This clinical trial randomizes ALI/ARDS patient low blood protein level receive albumin ( natural blood protein know influence inflammation ) hetastarch ( synthetic blood protein ) diuretic therapy target improve respiratory function . Therapeutic effect respiratory function blood oxygen level , extravascular lung water , oncotic pressure , lung fluid removal , heart function characterize . This trial advance understanding treatment ALI/ARDS factor affect fluid balance lung patient . Funding Source - FDA OOPD</brief_summary>
	<brief_title>Comparative Evaluation Albumin Starch Effects Acute Lung Injury ( ALI )</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Acute Lung Injury</mesh_term>
	<mesh_term>Lung Injury</mesh_term>
	<mesh_term>Hydroxyethyl Starch Derivatives</mesh_term>
	<criteria>Consensus clinical definition ALI ARDS : PaO2 / FiO2 ratio ≤ 200 ( ARDS ) ≤ 300 ( ALI ) , ; Bilateral infiltrate chest xray , ; No clinical evidence congestive heart failure , ; PAOP ≤ 18 mm Hg , pulmonary arterial catheter present Serum total protein concentration &lt; 6.0 g/dL . Endotracheal intubation mechanical ventilation ≥ 24 hour . Hemodynamic instability within prior 24 hour : ( either follow ) Ongoing fluid resuscitation define &gt; 2 liter crystalloid bolus &gt; 4 unit blood product transfuse prior 24hour period . Vasopressor support exceed follow : Dopamine dobutamine &gt; 5 mcg/kg/min , combination dose ; Any vasoactive agent ( i.e . epinephrine , norepinephrine , phenylephrine ) Significant renal disease ( either follow time screen ) : Endstage renal disease , Renal insufficiency serum creatinine ≥ 3.0 mg/dL urine output &lt; 500cc/24 hr Allergy albumin , hetastarch furosemide . Increased risk bleeding : Within 72 hour surgical procedure require use operating room , Any current previously diagnose bleed disorder , History intracranial abnormality ( include , limited , intracranial arteriovenous malformation , subdural/subarachnoid/intracerebral hemorrhage , intracranial mass lesion ) traumatic brain injury GCS &lt; 9 prior 14 day , Prothrombin time international normalize ratio ( INR ) &gt; 2.0 , partial thromboplastin time ( PTT ) &gt; 1.5 time control , platelet count &lt; 50,000/cc3 Risk worsen pulmonary edema due systolic heart failure . Technical pulse contour analysis limitation : Absence central venous catheter , clinical arterial vascular disease , severe hypothermia ( core temperature &lt; 94°F ) , weight &lt; 40 kg &gt; 250 kg , clinically significant bleed diathesis . Failure patient nearest relative provide inform consent . Refusal patient 's attend physician provide consent participate . Age &lt; 18 year . Pregnancy . Inability quantify urine output ( e.g . absence bladder bladder catheter ) . Significant hypokalemia ( K+ &lt; 3.5 meq/L ) , hypernatremia ( Na+ &gt; 155 meq/L ) hypomagnesemia ( Mg &lt; 1.0 meq/L ) Patient meet criterion wean mechanical ventilation : Required FiO2 ≤ 0.40 PEEP ≤ 5 , ; Spontaneous tidal volume &gt; 5 ml / kg , ; Spontaneous respiratory rate &lt; 20 / minute , ; Capable spontaneous ventilation CPAP=5 , PS=5 . Expected survival ≤ 120 hour .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Acute lung injury ( ALI )</keyword>
	<keyword>Acute respiratory distress syndrome ( ARDS )</keyword>
	<keyword>Respiratory failure</keyword>
</DOC>